Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Oogenesis02:07

Oogenesis

71.2K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boosting the Potency of T-cell Therapies.

Cancer discovery·2016
Same author

Two Unique Glioma Subtypes Revealed.

Cancer discovery·2016
Same author

Accelerating Lead Compound Optimization.

Cancer discovery·2016
Same author

Vaccinating against HPV: A Call to Action.

Cancer discovery·2016
Same author

Expanding Therapy for Neuroendocrine Tumors.

Cancer discovery·2016
Same author

Resensitizing Refractory ALK+ NSCLC: A Case Study.

Cancer discovery·2016

Related Experiment Video

Updated: Mar 24, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K

How Ovarian Cancer Evades Immune Scrutiny.

Alissa Poh

    Cancer Discovery
    |March 10, 2016
    PubMed
    Summary

    Scientists discovered that the protein SATB1 drives immunosuppression in ovarian tumors. Unremitting expression of SATB1 in dendritic cells causes them to become inflammatory, hindering anti-tumor immunity.

    Area of Science:

    • Immunology
    • Cancer Biology
    • Cell Biology

    Background:

    • Dendritic cells are crucial for initiating anti-tumor immune responses.
    • Ovarian tumors often contain abundant dendritic cells, yet these cells typically fail to stimulate anti-tumor immunity.

    Discussion:

    • This study identifies the protein SATB1 as a key regulator of dendritic cell function in the ovarian tumor microenvironment.
    • Unremitting expression of SATB1 in ovarian tumor-associated dendritic cells promotes an inflammatory and immunosuppressive phenotype.

    Key Insights:

    • SATB1 is transiently required for normal dendritic cell maturation.
    • Sustained SATB1 expression converts these immune cells into immunosuppressive agents within the tumor.
    • This finding sheds light on mechanisms of immune evasion in ovarian cancer.

    More Related Videos

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    3.3K
    A Proximal Culture Method to Study Paracrine Signaling Between Cells
    08:17

    A Proximal Culture Method to Study Paracrine Signaling Between Cells

    Published on: August 28, 2018

    10.2K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
    05:42

    Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

    Published on: January 26, 2024

    3.3K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    3.3K
    A Proximal Culture Method to Study Paracrine Signaling Between Cells
    08:17

    A Proximal Culture Method to Study Paracrine Signaling Between Cells

    Published on: August 28, 2018

    10.2K

    Outlook:

    • Targeting SATB1 in dendritic cells could represent a novel therapeutic strategy for ovarian cancer.
    • Further research may explore modulating SATB1 activity to restore anti-tumor immunity.